Ramaiah Muthyala - Publications
Affiliations: | 2000- | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Medicinal chemistryWebsite:
https://www.pharmacy.umn.edu/bio/experimental-and-clinical-phar/ramaiah-muthyalaYear | Citation | Score | |||
---|---|---|---|---|---|
2022 | Milicaj J, Hassan BA, Cote JM, Ramirez-Mondragon CA, Jaunbocus N, Rafalowski A, Patel KR, Castro CD, Muthyala R, Sham YY, Taylor EA. Discovery of first-in-class nanomolar inhibitors of heptosyltransferase I reveals a new aminoglycoside target and potential alternative mechanism of action. Scientific Reports. 12: 7302. PMID 35508636 DOI: 10.1038/s41598-022-10776-x | 0.312 | |||
2014 | Muthyala R, Rastogi N, Shin WS, Peterson ML, Sham YY. Cell permeable vanX inhibitors as vancomycin re-sensitizing agents Bioorganic and Medicinal Chemistry Letters. 24: 2535-2538. PMID 24751446 DOI: 10.1016/J.Bmcl.2014.03.097 | 0.415 | |||
2010 | Yaragorla S, Muthyala R. Concise total synthesis of cytotoxic natural products (+) and (-)-muricatacin Arkivoc. 2010. DOI: 10.3998/Ark.5550190.0011.A15 | 0.458 | |||
2010 | Yaragorla S, Muthyala R. Formal total synthesis of (−)-balanol: a potent PKC inhibitor Tetrahedron Letters. 51: 467-470. DOI: 10.1016/J.Tetlet.2009.10.120 | 0.476 | |||
1994 | Muthyala R, Katritzky AR, Lan X. A synthetic study on the preparation of triarylmethanes Dyes and Pigments. 25: 303-324. DOI: 10.1016/0143-7208(94)87017-9 | 0.417 | |||
Show low-probability matches. |